Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study

NCT02057211 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Changed regulations of culture procedure

Conditions

Type 1 Diabetes Mellitus

Interventions

BIOLOGICAL: autologous mesenchymal stem cell transplantation
PROCEDURE: sham transplantation of mesenchymal stem cells

Sponsor

Uppsala University Hospital